Product Overview

The E. coli Host Cell DNA Residue Detection Kit (USP) utilizes a TaqMan fluorescent probe-based qPCR method to accurately, efficiently, and specifically quantify residual Escherichia coli host cell DNA in intermediates, semi-finished products, and finished biologics, including recombinant proteins, antibodies, and vaccines. 

The assay is developed in accordance with USP General Chapter <509> Residual DNA Testing, ensuring a standardized and regulatory-aligned approach for residual DNA quantification in biopharmaceutical applications.

Background

Escherichia coli is one of the most widely used microbial expression hosts in the biopharmaceutical industry due to its rapid growth, high protein expression efficiency, and cost-effective manufacturing process. It is commonly used for the production of recombinant proteins, enzymes, vaccines, and plasmid DNA.

During upstream production, host cell DNA may be released into the manufacturing process and remain in the final product if not effectively removed. Regulatory agencies and pharmacopoeias require residual host cell DNA to be tightly controlled to ensure product safety and quality.

To support compliance with regulatory expectations, USP General Chapter <509> provides specific guidance for residual DNA testing, making qPCR-based detection a preferred analytical approach due to its high sensitivity, specificity, and quantitative accuracy.

Intended Use

The E. coli DNA Assay Kit (USP) is intended for the quantitative determination of residual E. coli host cell DNA in biological products using TaqMan fluorescent probe-based real-time PCR technology.

Suitable sample types include:

• Recombinant proteins

• Monoclonal antibodies

• Vaccines

• Enzyme preparations

• Plasmid DNA products

• Other biologics derived from E. coli expression systems

Applicable throughout:

• Process development

• Process validation

• In-process control

• Final product release testing

Key Features

USP-Referenced qPCR Assay

Developed using the primer and probe sequences specified in USP <509> Residual DNA Testing.

High Sensitivity

LOQ as low as 0.03 pg/μL (30 pg/mL) residual E. coli DNA.

Broad Dynamic Range

Accurate quantification from 0.03–300 pg/μL.

High Specificity

Selective detection of E. coli DNA with no significant cross-reactivity to non-target DNA.

Excellent Precision

Intra-assay and inter-assay CV values below 10%.

Suitable for QC and Release Testing

Applicable to recombinant proteins, antibodies, vaccines, enzymes, and other E. coli-derived biologics.

Applications

The E. coli DNA Assay Kit (USP) is suitable for residual host cell DNA monitoring throughout biologics manufacturing workflows.

Biopharmaceutical Development

• Process optimization

• DNA clearance evaluation

• Purification process assessment

Process Validation

• Residual DNA removal verification

• Manufacturing consistency studies

Quality Control Testing

• Raw material and intermediate testing

• Bulk drug substance testing

• Finished product release testing

Applicable Product Types

• Recombinant proteins

• Therapeutic enzymes

• Vaccines

• Antibody products

• Plasmid DNA products

• Other E. coli-derived biologics

Performance Data

High Sensitivity and Broad dynamic Range

1、The amplification plot was generated using a 10-fold serial dilution of E. Coli genomic DNA provided in the kit. Concentrations range from 0. 03-300 pg/uL.

2、The standard curve of the 10-fold dilution series. R²=0. 998.

High Sensitivity and LOQ as low as 30 pg/mL DNA

1、The amplification plot was generated using 30 pg of CHO cell genomic DNA (red), and negative control water (red), which indicates no amplification of nonspecific fragments.

2、The amplification plot was generated for 6 six times using 0. 03pg/uL of E. coli genomic DNA and the average Ct value is 32. 1. The limit of Quantification is 30 pg/mL DNA.

Analytical Performance Summary

Applicable Product Types

FAQ

Why does the assay show reduced sensitivity or LOQ performance variation?

Possible Cause 1: Degradation of standard DNA or improper storage

Store DNA standards at recommended conditions and avoid repeated freeze-thaw cycles, which may affect low-level detection performance.

Possible Cause 2: Inaccurate pipetting at low concentration range

At ultra-low concentrations (e.g., near LOQ), pipetting errors significantly impact results. Use calibrated pipettes and low-retention tips.

Possible Cause 3: Improper reaction setup or insufficient mixing

Ensure complete mixing of qPCR master mix, primers, probes, and template before amplification.

Why is there variability in repeatability or inter-assay results?

Possible Cause 1: Inconsistent sample handling across operators

Standardize sample preparation workflows and ensure all operators follow identical procedures.

Possible Cause 2: Improper magnetic bead-based extraction performance

Magnetic beads should be fully resuspended before use. Avoid bead loss during washing steps, as this may reduce DNA recovery consistency.

Possible Cause 3: Elution inefficiency or residual bead carryover

Ensure sufficient mixing during elution and avoid transferring magnetic beads into downstream reactions.

Why do negative controls show unexpected amplification?

Possible Cause 1: Cross-contamination during qPCR setup

Maintain strict workflow separation between pre-PCR and post-PCR areas. Use dedicated pipettes and filtered tips.

Possible Cause 2: Aerosol contamination of reagents or consumables

Replace reagents and consumables if contamination is suspected and prepare fresh reaction mixes.

Why does amplification efficiency deviate from expected range?

Possible Cause 1: Suboptimal reaction setup or reagent mixing

Ensure correct reaction composition and thorough mixing before loading the qPCR instrument.

Possible Cause 2: Pipetting inaccuracies in dilution series

Verify serial dilution preparation accuracy, especially in the standard curve setup from 0.03–300 pg/μL range.